Healthcare startups funding roundup week of June 28

Sword Health raised $85M; Tendo landed $50M: ObvioHealth secured $31M

Olive: Olive is a Columbus, Oh.-based developer of health care services bots. Olive has raised $400 million in fresh funding co-led by Vista Equity Partners and Base10 Partners, with participation from Tiger Global. Read more

Carbon Health: Carbon Health, a San Francisco-based primary and urgent healthcare company, is reportedly in talks to raise new funding at a $3 billion valuation after shelving talks to go public through a blank-check company. According to Bloomberg, the round being discussed is around $300 million and includes Blackstone Group and Capital Group. More here.

4G Clinical: 4G Clinical is a Wellesley, Ma.-based company that creates software to run the back-end of clinical trials. 4G Clinical has raised more than $200 million in a new growth equity round led by Goldman Sachs. Read more

HealthVerity: HealthVerity is a Philadelphia, Pa.-based medical data marketplace. HealthVerity has raised $100 million in Series D funding led by Durable Capital Partners, with participation from Flare Capital Partners, Foresite Capital and Greycroft. Read more

Sword Health: Sword Health is a New York-based virtual therapy platform that pairs expert physical therapists with FDA-listed wearable technology to treat patients needing musculoskeletal care. Sword Health  has raised $85 million in Series C funding. General Catalyst led the round; other participants included Bond, Highmark Ventures, BPEA, Khosla Ventures, Founders Fund, Transformation Capital and Green Innovations. Read more 

Antheia: Antheia is a Menlo Park, Ca.-based startup using synthetic biology to produce medicines currently sourced from plants. Antheia has raised $73 million in Series B funding led by Viking Global Investors, Sherpalo Ventures and Hillspire. Read more  

Tendo Systems: Tendo Systems is  a healthcare software company aiming to foster digital engagement between patients, clinicians, and caregivers.  Tendo announced a $50 million funding Series B round led by existing investor Lux Capital, with participation from Series A lead investor General Catalyst. Read more

ObvioHealth: ObvioHealth calls itself a "Virtual Research Organization." The company provides a DCT app, which can be downloaded onto a smartphone, so that anyone can participate in clinical trials from anywhere. ObvioHealth has raised $31 million led by new investors Dedalus Group and Novotech. Read more

Babson Diagnostics: Babson Diagnostics is a Austin, Tex.-based diagnostic blood testing company. Babson Diagnostics has raised $31 million in Series B funding led by Emerald Development Managers, with participation from earlier investors Siemens Healthineers, Prism Ventures, and Lago Consulting Group. Read more

If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to kristin@vator.tv. If you want a longer write-up, please do give us a couple of days heads up. If you'd like to be included in our Today's Entrepreneur column, please send me your Vator profile. 

Image by PublicDomainPictures from Pixabay